{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:19:22Z","timestamp":1777727962879,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["BIRAC \/ BT\/NBM0095\/02\/18"],"award-info":[{"award-number":["BIRAC \/ BT\/NBM0095\/02\/18"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.virol.2025.110620","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:11:42Z","timestamp":1751422302000},"page":"110620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Performance evaluation of micro-foci reduction neutralization test for the detection of neutralizing antibodies in human samples against dengue viruses circulating in India"],"prefix":"10.1016","volume":"610","author":[{"given":"Shweta","family":"Chelluboina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Borkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh","family":"Chandra Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya A.","family":"Arankalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5980-8536","authenticated-orcid":false,"given":"Shubham","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110620_bib1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4269\/ajtmh.14-0145","article-title":"Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos, Mexico","volume":"91","author":"Amaya-Larios","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-023-00378-7","article-title":"Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection","volume":"3","author":"Anantharaj","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.virol.2025.110620_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12985-018-0967-x","volume":"15","author":"Azami","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2025.110620_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-5-1","article-title":"Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India","volume":"5","author":"Bharaj","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2025.110620_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110620_bib6","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-specific neutralization and protection by antibodies against dengue virus type 3","volume":"84","author":"Brien","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110620_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003230","article-title":"Dengue virus neutralizing antibody levels associated with protection from infection in Thai cluster studies","volume":"8","author":"Buddhari","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234236","article-title":"Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America","volume":"15","author":"Carpp","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110620_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.apjtm.2016.12.002","article-title":"Serodiagnosis of asymptomatic dengue infection","volume":"10","author":"Chatchen","year":"2017","journal-title":"Asian Pac. J. Tropical Med."},{"key":"10.1016\/j.virol.2025.110620_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/insects12060554","article-title":"Serosurvey of Nonhuman Primates in Costa Rica at the human\u2013wildlife interface reveals high exposure to flaviviruses","volume":"12","author":"Chaves","year":"2021","journal-title":"Insects"},{"key":"10.1016\/j.virol.2025.110620_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/trstmh\/try070","article-title":"Implementing a dengue vaccination programme\u2014who, where and how?","volume":"112","author":"Clapham H","year":"2018","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/s12879-016-1867-6","article-title":"High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil","volume":"16","author":"de Teive e Argolo","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-017-0384-1","article-title":"Seroprevalence of dengue among healthy adults in a rural community in Southern Malaysia: a pilot study","volume":"7","author":"Dhanoa","year":"2018","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.virol.2025.110620_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/382280","article-title":"Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand","volume":"189","author":"Endy","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.55","article-title":"Dengue infection","volume":"2","author":"Guzman","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.virol.2025.110620_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/pathogens13010008","article-title":"Utility of an In-Vitro micro-neutralizing Test in comparison to a plaque reduction neutralization test for dengue virus, Japanese encephalitis virus, and zika virus serology and drug screening","volume":"13","author":"Haga","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2025.110620_bib17","first-page":"4659","article-title":"Participants in the summit on dengue immune correlates of protection","volume":"35","author":"Katzelnick","year":"2017","journal-title":"Immune correlates of protection for dengue: State of the art and research agenda. Vaccine"},{"key":"10.1016\/j.virol.2025.110620_bib18","article-title":"A microneutralization assay for dengue viruses using mosquito C6\/36 cells","author":"Kim","year":"2013","journal-title":"Acta Virol."},{"key":"10.1016\/j.virol.2025.110620_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006342","article-title":"Development and evaluation of a novel high-throughput image-based fluorescent neutralization test for detection of Zika virus infection","volume":"12","author":"Koishi","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4269\/ajtmh.14-0671","article-title":"Dengue seroprevalence of healthy adults in Singapore: serosurvey among blood donors, 2009","volume":"93","author":"Low","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00867-17","article-title":"Potent plasmablast-derived antibodies elicited by the national institutes of health dengue vaccine","volume":"91","author":"Magnani","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110620_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jviromet.2005.12.002","article-title":"An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies","volume":"134","author":"Martin","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2025.110620_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027252","article-title":"Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes","volume":"6","author":"Mattia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110620_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4269\/ajtmh.2008.79.678","article-title":"Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity","volume":"79","author":"McArthur","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006657","article-title":"Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India. Beasley DWC","volume":"12","author":"Mishra","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000670","article-title":"Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission","volume":"4","author":"Morrison","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1208\/s12248-023-00830-5","article-title":"Neutralizing antibody validation testing and reporting harmonization","volume":"25","author":"Myler","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.virol.2025.110620_bib28","article-title":"Guidelines for plaque reduction neutralization testing of human antibodies to dengue","author":"Organization","year":"2007","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110620_bib29","first-page":"257","article-title":"Differences in the replicative capacities of clinical isolates of dengue virus in C6\/36 cells and in urban populations of Aedes aegypti from Colombia, South America","volume":"22","author":"Quintero-Gil","year":"2018","journal-title":"Braz J Infect Dis Off Publ Braz Soc Infect Dis"},{"key":"10.1016\/j.virol.2025.110620_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1471-2334-12-233","article-title":"Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis","volume":"12","author":"Rainwater-Lovett","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4269\/ajtmh.2009.80.61","article-title":"An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells","volume":"80","author":"Rodrigo","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virol.2025.110620_bib33","first-page":"285","article-title":"A plaque reduction test for dengue virus neutralizing antibodies","volume":"99","author":"Russell","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.virol.2025.110620_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002952","article-title":"Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development","volume":"8","author":"Salje","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2025.110620_bib35","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/JCM.00975-17","article-title":"Evaluation of a novel reporter virus neutralization test for serological diagnosis of zika and dengue virus infection","volume":"55","author":"Shan","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2025.110620_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biologicals.2012.09.005","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.virol.2025.110620_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1743-422X-11-48","article-title":"Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand","volume":"11","author":"Sirivichayakul","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2025.110620_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2180-14-44","article-title":"A novel reporter system for neutralizing and enhancing antibody assay against dengue virus","volume":"14","author":"Song","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.virol.2025.110620_bib39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance","volume":"81","author":"Thomas","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104909","article-title":"Complete genome characterization and evolutionary analysis of dengue viruses isolated during 2016\u20132017 in Pune, India","volume":"93","author":"Tiraki","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.virol.2025.110620_bib42","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1017\/S0950268817001479","article-title":"Co-circulation and co-infections of all dengue virus serotypes in Hyderabad, India 2014","volume":"145","author":"Vaddadi","year":"2017","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.virol.2025.110620_bib43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jiph.2013.01.004","article-title":"Episode of coexisting infections with multiple dengue virus serotypes in central Karnataka, India","volume":"6","author":"Vinodkumar","year":"2013","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.virol.2025.110620_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4269\/ajtmh.2002.66.208","article-title":"Enzyme-linked immunosorbent assay-format microneutralization test for dengue viruses","volume":"66","author":"Vorndam","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib45","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4269\/ajtmh.17-0948","article-title":"Virus reduction neutralization test: a single-cell imaging high-throughput virus neutralization assay for dengue","volume":"99","author":"Whiteman","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2025.110620_bib46","series-title":"Informing Vaccination Programs: a Guide to the Design and Conduct of Dengue Serosurveys","year":"2017"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:50:56Z","timestamp":1777459856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225002338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S0042682225002338"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110620","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance evaluation of micro-foci reduction neutralization test for the detection of neutralizing antibodies in human samples against dengue viruses circulating in India","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110620"}}